| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |